Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib and Capecitabine in HER2+ Advanced Breast Cancer
NCT00508274Phase 3Terminated
- Sponsor
- Novartis
- Start
- Jul 2007
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of lapatinib in breast cancer, sponsored by Novartis. Started Jul 2007; status: terminated.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00508274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00508274.